Literature DB >> 27412678

Hospital Exemption for Advanced Therapy Medicinal Products: Issue in Application in the European Union Member States.

Tatjana Ivaskiene, Mykolas Mauricas, Justinas Ivaska1.   

Abstract

Regulation (EC) 1394/2007 of the European Parliament and the Council on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004 allowed the use of non - authorized advanced therapy medicinal products under the certain circumstances. This socalled hospital exemption rule needs to be applied in the each Member State of the European Union individually and for this purpose Member States should provide national procedures and control measures. The aim of this article is to clear up the criteria for hospital exemption listed in Regulation (EC) 1394/2007 and to contrast the difference in implementing hospital exemption rule into national legal regimes on examples of the United Kingdom, Lithuania and Poland.

Mesh:

Year:  2017        PMID: 27412678     DOI: 10.2174/1574888x11666160714114854

Source DB:  PubMed          Journal:  Curr Stem Cell Res Ther        ISSN: 1574-888X            Impact factor:   3.828


  5 in total

Review 1.  Optimization of Mesenchymal Stromal Cell (MSC) Manufacturing Processes for a Better Therapeutic Outcome.

Authors:  Maria Eugenia Fernández-Santos; Mariano Garcia-Arranz; Enrique J Andreu; Ana Maria García-Hernández; Miriam López-Parra; Eva Villarón; Pilar Sepúlveda; Francisco Fernández-Avilés; Damian García-Olmo; Felipe Prosper; Fermin Sánchez-Guijo; Jose M Moraleda; Agustin G Zapata
Journal:  Front Immunol       Date:  2022-06-09       Impact factor: 8.786

2.  Trends in clinical trials for articular cartilage repair by cell therapy.

Authors:  Takaharu Negoro; Yuri Takagaki; Hanayuki Okura; Akifumi Matsuyama
Journal:  NPJ Regen Med       Date:  2018-10-11

Review 3.  Stem Cell Therapy: From Idea to Clinical Practice.

Authors:  Mohammad Mousaei Ghasroldasht; Jin Seok; Hang-Soo Park; Farzana Begum Liakath Ali; Ayman Al-Hendy
Journal:  Int J Mol Sci       Date:  2022-03-05       Impact factor: 5.923

Review 4.  Bringing Advanced Therapies for Parkinson's Disease to the Clinic: An Analysis of Ethical Issues.

Authors:  Kristina Hug
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

5.  Value-based pricing for advanced therapy medicinal products: emerging affordability solutions.

Authors:  Elisabete Gonçalves
Journal:  Eur J Health Econ       Date:  2021-06-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.